🔎 Trials Near Me

Beranda › Melanoma › Washington › Seattle

Uji klinis Melanoma di Seattle, WA

17 studi untuk Melanoma mencari peserta di lokasi sekitar Seattle (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Swedish Medical Center-Ballard Campus, Seattle
  • Swedish Medical Center-Cherry Hill, Seattle
  • Swedish Medical Center-First Hill, Seattle
  • dan 1 lainnya
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069

A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)

Menerima pesertaFase 2
  • Fred Hutchinson Cancer Center ( Site 4041), Seattle
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06961006

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Menerima pesertaFase 3
  • Swedish Cancer Institute, Seattle
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06246916

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

Menerima pesertaFase 3
  • Fred Hutchinson Cancer Center, Seattle
  • University of Washington Medical Center - Montlake, Seattle
  • Saint Joseph Medical Center Hematology and Oncology - Silverdale, Silverdale · 17 mi jauhnya
Usia 75 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT07068074

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

Menerima pesertaFase 1/2
  • University of Washington Fred Hutchinson Cancer Center, Seattle
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06814496

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

Menerima pesertaFase 2
  • Local Institution - 0086, Seattle
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07492680

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

Menerima pesertaFase 2
  • Swedish Medical Center-Ballard Campus, Seattle
  • Swedish Medical Center-Cherry Hill, Seattle
  • Swedish Medical Center-First Hill, Seattle
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT04511013

Project: Every Child for Younger Patients With Cancer

Menerima pesertaStudi observasional
  • Seattle Children's Hospital, Seattle
Hingga usia 25 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT02402244

High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial

Menerima peserta
  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT06298734

Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer

Menerima pesertaFase 1
  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Jul 2026 · NCT05098210

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Menerima pesertaFase 1/2
  • Virginia Mason Medical Center, Seattle
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Mei 2026 · NCT05379985

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

Menerima pesertaFase 1/2
  • Fred Hutchinson Cancer Center, Seattle
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Mei 2026 · NCT03686124

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Menerima pesertaFase 2/3
  • Fred Hutchinson Cancer Center, Seattle
Semua usia · Semua jenis kelamin · Diperbarui 2 Apr 2026 · NCT06581406

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Menerima pesertaStudi observasional
  • Kaiser Permanente Washington, Seattle
  • Swedish Medical Center-First Hill, Seattle
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Mar 2026 · NCT06418204

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

Menerima pesertaFase 3
  • Fred Hutchinson Cancer Center, Seattle
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Feb 2026 · NCT05549297

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Menerima pesertaStudi observasional
  • Massive Bio SYNERGY-AI site, Seattle
Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774

A Study of IBI363 in Subjects with Advanced Solid Malignancies

Menerima pesertaFase 2
  • Fred Hutchinson Cancer Center, Seattle
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Des 2024 · NCT06281678

Uji klinis Melanoma di kota lain

Studi lain di Seattle

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.